Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts

Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter

Conference/Earnings Calls Alerts

Marksans Pharma Ltd.

05 Jun 2024

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Kindly find attached transcript of earnings call Q4FY24

Marksans Pharma Ltd.

31 May 2024

231.55

-1.99%

Marksans Pharma Results Earnings Call for Q4FY24

Conference Call with Marksans Pharma Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.

Marksans Pharma Ltd.

31 May 2024

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Kindly find attached

Marksans Pharma Ltd.

20 Feb 2024

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Kindly find enclosed the transcript of investors/analysts meet for Q3FY24 financial performance

Marksans Pharma Ltd.

14 Feb 2024

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording link of investors/analysts meet fir Q3FY24

Marksans Pharma Ltd.

16 Nov 2023

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to regulation 30, please find enclosed the transcript of the investors / analysts meet for Q2FY2024 held on November 09, 2023

Marksans Pharma Ltd.

09 Nov 2023

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to regulation 30 of SEBI (LODR) regulations, 2015, the Company has uploaded the audio recording of investors/analysts meet for Q2FY24 financial performance and strategy update held today i.e. November 09, 2023 on the Company website

Marksans Pharma Ltd.

22 Aug 2023

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to regulation 30 read with para A of schedule III of SEBI (LODR) Regulations, 2015, kindly find enclosed the transcript of the investors / analysts meet for Q1FY2024. The information is also available on the website of the Company.

Marksans Pharma Ltd.

17 Aug 2023

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the aforesaid Financial Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.html

Marksans Pharma Ltd.

07 Jun 2023

231.55

-1.99%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q4 FY23 Earnings Conference Call held on May 31, 2023